Loading stock data…
NRC
$17.41+0.95 (+5.77%)
Market ClosedLast close May 1
National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NRC Health in the Healthcare sector is trading at $17.41. The stock is currently 24% below its 52-week high of $22.79, remaining 11.7% above its 200-day moving average. Technical signals show neutral RSI of 56 and bearish MACD signal, explaining why NRC maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 56) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$17.41
Potential Upside
24.7%
Whystock Fair Value$21.70
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$398.06M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
35.00
Beta
Defensive asset. Lower volatility than the S&P 500.
0.41
Div Yield
Strong income play. Yield provides a meaningful total return floor.
320.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
128.16%
Volume
Today's trading volume
164,383
Recent News
NRC Health's Q1 Earnings Fall Y/Y Due to Elevated Operating Costs
NRC's Q1 earnings per share decline year over year amid rising costs, though the company delivered revenue growth and strong contract value gains.
NRC Health (NRC) Q1 2026 Earnings Call Highlights: Record TRCV and Landmark Deals Propel Growth
NRC Health (NRC) reports a 13% increase in TRCV and unveils a $60 million share repurchase authorization amid strategic expansions.
National Research Q1 Earnings Call Highlights
National Research (NASDAQ:NRC) executives highlighted improving growth trends and a record customer win during the company’s first-quarter 2026 earnings call, pointing to rising recurring contract value, a return to year-over-year revenue growth, and expectations for margin expansion later in the ye
NRC Health Surges 62% in a Year: Should You Buy the Stock?
Strong recurring revenues, rising AI adoption and alignment with value-based care trends position NRC to capitalize on growing demand for patient-centric healthcare solutions.
TSX Penny Stocks With Market Caps Over CA$100M To Consider
By the end of last week, markets rebounded from the lows, and the S&P 500 and Canadian TSX indexes were positive for the week after negative returns in March. Despite ongoing uncertainty and elevated oil prices, there are signs that de-escalation may be on the horizon. Penny stocks, a term that might seem outdated yet remains significant, represent smaller or newer companies with potential for growth when backed by strong financials. In this article, we explore three penny stocks that combine...